NXTS vs GRFS Stock Comparison

Nexentis Technologies and Grifols Prices as of Oct 26, 2026 Peers: Industry group
GRFS Grifols SA
$7.92 +7.8% 1M -16.3% 1Y
Market cap
$5.52B
P/E
11.9x
Revenue (TTM)
—
Div. yield
–
Biotechnology Healthcare
5 wins

Head to Head

5 decided of 12

Grifols leads on 5 of the 12 questions below (Grifols 5). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionNXTSGRFSLeader
Larger companyMarket capitalisation $465.12K $5.52B GRFS
Cheaper on earningsLower P/E, profitable companies only 0.0x 11.9x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 8.4x –
Faster revenue growthRevenue growth, trailing twelve months — — –
More profitableNet margin, trailing twelve months — — –
Better return on capitalReturn on invested capital — — –
Less leveragedLower net debt / EBITDA 1.6x — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -97.9% -16.3% GRFS
Better 5-year returnAnnualised price return, 5 years -86.1%/yr -9.9%/yr GRFS
Less volatileAnnualised volatility, 1 year 169.1% 32.4% GRFS
Higher overall scoreMean of the five percentile scores vs peers 32/100 57/100 GRFS

Percentile Scorecard

NXTSGRFS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisNXTSGRFS
Valuation – 99 #6 of 626
Growth 13 #526 of 604 –
Profitability 40 #333 of 555 –
Financial Health 44 #372 of 658 14 #566 of 658
Shareholder Returns – 56 #161 of 368
Overall 32 57
  • NXTS ranked among 673 companies in Pharmaceuticals and Biotechnology
  • GRFS ranked among 673 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodNXTSGRFSSPY
1 month -61.9%+7.8% -0.8%
3 months -66.5%+2.2% +3.5%
6 months -88.4%-2.6% +7.0%
Year to date -95.2%-15.3% +12.2%
1 year -97.9%-16.3% +13.0%
3 years -99.9%+1.0% +86.3%
3 years, per year -89.6%+0.3% +23.1%
5 years -100.0%-40.5% +68.6%
5 years, per year -86.1%-9.9% +11.0%
10 years -100.0%-46.6% +258.0%
10 years, per year -66.6%-6.1% +13.6%

Risk

MeasureNXTSGRFSSPY
Volatility, 1Y 169.1%32.4% 12.7%
Downside volatility, 1Y 153.3%34.1% 12.7%
Beta vs S&P 500, 1Y 2.310.95 1.00
Return / volatility, 1Y -0.58-0.50 1.02
Max drawdown, 5Y -100.0%-58.9% -25.4%
From 52-week high -97.8%-18.5% -1.8%
52-week high $26.04$9.72 $779.14
52-week low $0.53$7.02 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleNXTSGRFS
P/E now vs peer median 0.0xmedian 17.1x 11.9xmedian 17.1x
P/S now vs peer median —median 8.8x 0.6xmedian 8.8x
EV/EBITDA now vs peer median 1.5xmedian 17.1x —median 17.1x
P/FCF now vs peer median —median 18.0x 7.6xmedian 18.0x
P/B now vs peer median 0.2xmedian 2.1x 0.6xmedian 2.1x
PEG now vs peer median 0.00median 0.31 —median 0.31

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsNXTSGRFS
Operating income -$5.28M –
Net income -$14.06M –
R&D $532.00K –
EPS (diluted) $-17.10 –
Cash & equivalents $7.62M $969.15M
Total debt $3.22M $44.00B
Shares (diluted) 816.14K 681.57M
Enterprise value -$22.18M $1.86B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricNXTSGRFS
P/E 0.0x 11.9x
P/FCF – 7.6x
P/Operating cash flow – –
P/S – 0.6x
P/B 0.2x 0.6x
P/Tangible book -0.2x 0.9x
EV/EBITDA 1.5x –
EV/EBIT 1.5x –
EV/Revenue – –
EV/FCF – –
EV/Operating cash flow – –
PEG (3Y EPS CAGR) 0.00 –

Growth

14 metrics
MetricNXTSGRFS
Revenue growth (1Y) – –
Revenue CAGR (3Y) – –
Gross profit growth (1Y) – –
Gross profit CAGR (3Y) – –
Operating income growth (1Y) -7.7% –
Operating income CAGR (3Y) 3.0% –
Net income growth (1Y) -48.2% –
Net income CAGR (3Y) -35.8% –
EPS growth (1Y) -567.8% –
EPS CAGR (3Y) -45.2% –
Operating cash flow growth (1Y) – –
Operating cash flow CAGR (3Y) – –
Free cash flow growth (1Y) – –
Free cash flow CAGR (3Y) – –

Profitability

14 metrics
MetricNXTSGRFS
Gross margin – –
EBITDA margin – –
Operating margin – –
Pretax margin – –
Net margin – –
FCF margin – –
Operating cash flow margin – –
Return on equity -157.0% –
Return on assets -71.9% –
Return on invested capital – –
Return on capital employed -31.5% –
Asset turnover – –
Cash conversion (OCF / net income) – –
Stock comp / revenue – –

Financial Health

11 metrics
MetricNXTSGRFS
Debt / assets 2.3% 48.9%
Debt / equity 0.2x 1.3x
Net debt / EBITDA 1.6x –
Debt / FCF – –
Liabilities / assets 89.8% 61.4%
Equity / assets 10.2% 38.6%
Interest coverage – –
Current ratio 3.7x 2.5x
Quick ratio 3.2x 0.8x
Cash ratio 3.2x 0.4x
Altman Z-score – –

Shareholder Returns

7 metrics
MetricNXTSGRFS
Dividend yield – 1.4%
Net buyback yield – –
Shareholder yield – 1.4%
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusNXTSGRFS
Forward P/E – 8.4xFY2026
EPS, next fiscal year – $0.94FY2026
EPS growth, next FY – +10.6%FY2026
EPS growth, the year after – +26.6%
Revenue, next fiscal year – $8.88BFY2026
Revenue growth, next FY – +0.0%FY2026
Revenue growth, the year after – +10.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersNXTSGRFS
Held by institutions – 21.0%
Institutions holding – 166
Change in shares held, QoQ – -0.5%
Institutions buying – 73
Institutions selling – 65
Buyers to sellers – 1.12

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

NXTSGRFS
NXTS 1.00 0.03
GRFS 0.03 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, NXTS and GRFS?

Grifols (GRFS) is the largest by market capitalisation: Nexentis Technologies (NXTS) $465.12K, Grifols (GRFS) $5.52B.

Which stock has performed better?

Over the past year Grifols (GRFS) returned the most: Nexentis Technologies (NXTS) -97.9%, Grifols (GRFS) -16.3%. Over five years, Grifols (GRFS) compounded fastest (Nexentis Technologies (NXTS) -86.1%/yr, Grifols (GRFS) -9.9%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Grifols (GRFS) has been the steadiest (Nexentis Technologies (NXTS) 169.1%, Grifols (GRFS) 32.4%). Volatility measures how widely the price swings, not the risk of the business.

Do NXTS and GRFS move together?

Their daily returns over the past year have a correlation of 0.03, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, NXTS and GRFS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Grifols (GRFS) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.